Logo image of IAS

INTEGRAL AD SCIENCE HOLDING (IAS) Stock Fundamental Analysis

USA - NASDAQ:IAS - US45828L1089 - Common Stock

10.21 USD
-0.01 (-0.1%)
Last: 10/31/2025, 5:51:36 PM
10.2101 USD
0 (0%)
After Hours: 10/31/2025, 5:51:36 PM
Fundamental Rating

6

IAS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 94 industry peers in the Media industry. IAS is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. IAS is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year IAS was profitable.
In the past year IAS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: IAS reported negative net income in multiple years.
Each year in the past 5 years IAS had a positive operating cash flow.
IAS Yearly Net Income VS EBIT VS OCF VS FCFIAS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

The Return On Assets of IAS (4.76%) is better than 77.66% of its industry peers.
Looking at the Return On Equity, with a value of 5.19%, IAS is in the better half of the industry, outperforming 65.96% of the companies in the same industry.
IAS has a Return On Invested Capital (4.52%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for IAS is significantly below the industry average of 8.50%.
The last Return On Invested Capital (4.52%) for IAS is above the 3 year average (2.15%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.76%
ROE 5.19%
ROIC 4.52%
ROA(3y)1.74%
ROA(5y)-0.65%
ROE(3y)2.15%
ROE(5y)-1.58%
ROIC(3y)2.15%
ROIC(5y)N/A
IAS Yearly ROA, ROE, ROICIAS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -5 -10

1.3 Margins

IAS has a better Profit Margin (9.79%) than 80.85% of its industry peers.
IAS has a better Operating Margin (12.70%) than 70.21% of its industry peers.
Looking at the Gross Margin, with a value of 78.03%, IAS belongs to the top of the industry, outperforming 91.49% of the companies in the same industry.
In the last couple of years the Gross Margin of IAS has remained more or less at the same level.
Industry RankSector Rank
OM 12.7%
PM (TTM) 9.79%
GM 78.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.89%
GM growth 5Y-1.46%
IAS Yearly Profit, Operating, Gross MarginsIAS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IAS is destroying value.
The number of shares outstanding for IAS has been increased compared to 1 year ago.
Compared to 5 years ago, IAS has more shares outstanding
IAS has a better debt/assets ratio than last year.
IAS Yearly Shares OutstandingIAS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
IAS Yearly Total Debt VS Total AssetsIAS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

IAS has an Altman-Z score of 11.35. This indicates that IAS is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 11.35, IAS belongs to the top of the industry, outperforming 95.74% of the companies in the same industry.
There is no outstanding debt for IAS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 11.35
ROIC/WACC0.53
WACC8.48%
IAS Yearly LT Debt VS Equity VS FCFIAS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 3.64 indicates that IAS has no problem at all paying its short term obligations.
IAS's Current ratio of 3.64 is amongst the best of the industry. IAS outperforms 94.68% of its industry peers.
IAS has a Quick Ratio of 3.64. This indicates that IAS is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of IAS (3.64) is better than 94.68% of its industry peers.
Industry RankSector Rank
Current Ratio 3.64
Quick Ratio 3.64
IAS Yearly Current Assets VS Current LiabilitesIAS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 3300.00% over the past year.
The Revenue has grown by 14.40% in the past year. This is quite good.
IAS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.95% yearly.
EPS 1Y (TTM)3300%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)14.4%
Revenue growth 3Y17.89%
Revenue growth 5Y19.95%
Sales Q2Q%15.66%

3.2 Future

IAS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 33.52% yearly.
The Revenue is expected to grow by 11.50% on average over the next years. This is quite good.
EPS Next Y52.06%
EPS Next 2Y31.29%
EPS Next 3Y33.52%
EPS Next 5YN/A
Revenue Next Year14.52%
Revenue Next 2Y12.92%
Revenue Next 3Y12.39%
Revenue Next 5Y11.5%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
IAS Yearly Revenue VS EstimatesIAS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
IAS Yearly EPS VS EstimatesIAS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4

5

4. Valuation

4.1 Price/Earnings Ratio

IAS is valuated quite expensively with a Price/Earnings ratio of 30.03.
Based on the Price/Earnings ratio, IAS is valued a bit cheaper than 60.64% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.10, IAS is valued at the same level.
Based on the Price/Forward Earnings ratio of 25.75, the valuation of IAS can be described as expensive.
IAS's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.52. IAS is around the same levels.
Industry RankSector Rank
PE 30.03
Fwd PE 25.75
IAS Price Earnings VS Forward Price EarningsIAS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

IAS's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, IAS is valued a bit cheaper than 62.77% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.58
EV/EBITDA 11.6
IAS Per share dataIAS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IAS has a very decent profitability rating, which may justify a higher PE ratio.
IAS's earnings are expected to grow with 33.52% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.58
PEG (5Y)N/A
EPS Next 2Y31.29%
EPS Next 3Y33.52%

0

5. Dividend

5.1 Amount

No dividends for IAS!.
Industry RankSector Rank
Dividend Yield N/A

INTEGRAL AD SCIENCE HOLDING

NASDAQ:IAS (10/31/2025, 5:51:36 PM)

After market: 10.2101 0 (0%)

10.21

-0.01 (-0.1%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-06 2025-11-06/amc
Inst Owners58.61%
Inst Owner Change0.39%
Ins Owners0.82%
Ins Owner Change33.07%
Market Cap1.70B
Revenue(TTM)569.84M
Net Income(TTM)55.76M
Analysts54
Price Target11.92 (16.75%)
Short Float %6.54%
Short Ratio1.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)115.58%
Min EPS beat(2)78.78%
Max EPS beat(2)152.38%
EPS beat(4)3
Avg EPS beat(4)63.39%
Min EPS beat(4)-16.56%
Max EPS beat(4)152.38%
EPS beat(8)5
Avg EPS beat(8)-248.99%
EPS beat(12)9
Avg EPS beat(12)-94.66%
EPS beat(16)11
Avg EPS beat(16)-72.28%
Revenue beat(2)2
Avg Revenue beat(2)2.98%
Min Revenue beat(2)2.82%
Max Revenue beat(2)3.15%
Revenue beat(4)3
Avg Revenue beat(4)0.88%
Min Revenue beat(4)-4.27%
Max Revenue beat(4)3.15%
Revenue beat(8)7
Avg Revenue beat(8)1.54%
Revenue beat(12)11
Avg Revenue beat(12)1.62%
Revenue beat(16)15
Avg Revenue beat(16)2.28%
PT rev (1m)-10.17%
PT rev (3m)-12.41%
EPS NQ rev (1m)-1.27%
EPS NQ rev (3m)1.3%
EPS NY rev (1m)0.26%
EPS NY rev (3m)29.35%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)0.61%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)1.17%
Valuation
Industry RankSector Rank
PE 30.03
Fwd PE 25.75
P/S 2.99
P/FCF 15.58
P/OCF 11.22
P/B 1.59
P/tB 8.05
EV/EBITDA 11.6
EPS(TTM)0.34
EY3.33%
EPS(NY)0.4
Fwd EY3.88%
FCF(TTM)0.66
FCFY6.42%
OCF(TTM)0.91
OCFY8.91%
SpS3.42
BVpS6.43
TBVpS1.27
PEG (NY)0.58
PEG (5Y)N/A
Graham Number7.02
Profitability
Industry RankSector Rank
ROA 4.76%
ROE 5.19%
ROCE 6.59%
ROIC 4.52%
ROICexc 4.93%
ROICexgc 34.04%
OM 12.7%
PM (TTM) 9.79%
GM 78.03%
FCFM 19.19%
ROA(3y)1.74%
ROA(5y)-0.65%
ROE(3y)2.15%
ROE(5y)-1.58%
ROIC(3y)2.15%
ROIC(5y)N/A
ROICexc(3y)2.35%
ROICexc(5y)N/A
ROICexgc(3y)21.82%
ROICexgc(5y)N/A
ROCE(3y)3.13%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.89%
GM growth 5Y-1.46%
F-Score6
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 63.58%
Cap/Sales 7.46%
Interest Coverage 250
Cash Conversion 109.06%
Profit Quality 196.08%
Current Ratio 3.64
Quick Ratio 3.64
Altman-Z 11.35
F-Score6
WACC8.48%
ROIC/WACC0.53
Cap/Depr(3y)52.63%
Cap/Depr(5y)38.91%
Cap/Sales(3y)6.28%
Cap/Sales(5y)5.42%
Profit Quality(3y)639.69%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3300%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y52.06%
EPS Next 2Y31.29%
EPS Next 3Y33.52%
EPS Next 5YN/A
Revenue 1Y (TTM)14.4%
Revenue growth 3Y17.89%
Revenue growth 5Y19.95%
Sales Q2Q%15.66%
Revenue Next Year14.52%
Revenue Next 2Y12.92%
Revenue Next 3Y12.39%
Revenue Next 5Y11.5%
EBIT growth 1Y64.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year255%
EBIT Next 3Y66.13%
EBIT Next 5Y42.29%
FCF growth 1Y46.8%
FCF growth 3Y15.7%
FCF growth 5YN/A
OCF growth 1Y49.87%
OCF growth 3Y22.84%
OCF growth 5YN/A

INTEGRAL AD SCIENCE HOLDING / IAS FAQ

Can you provide the ChartMill fundamental rating for INTEGRAL AD SCIENCE HOLDING?

ChartMill assigns a fundamental rating of 6 / 10 to IAS.


What is the valuation status of INTEGRAL AD SCIENCE HOLDING (IAS) stock?

ChartMill assigns a valuation rating of 5 / 10 to INTEGRAL AD SCIENCE HOLDING (IAS). This can be considered as Fairly Valued.


What is the profitability of IAS stock?

INTEGRAL AD SCIENCE HOLDING (IAS) has a profitability rating of 6 / 10.


What are the PE and PB ratios of INTEGRAL AD SCIENCE HOLDING (IAS) stock?

The Price/Earnings (PE) ratio for INTEGRAL AD SCIENCE HOLDING (IAS) is 30.03 and the Price/Book (PB) ratio is 1.59.


Can you provide the financial health for IAS stock?

The financial health rating of INTEGRAL AD SCIENCE HOLDING (IAS) is 8 / 10.